A comprehensive, modular suite of bioprocess capabilities — tailored precisely to your protein, your timeline, and your program goals.
Microbial & mammalian expression system optimization
We eliminate development bottlenecks by selecting and optimizing the ideal expression system for your specific protein. Our expertise spans microbial (E. coli, yeast) and eukaryotic (mammalian cell lines) hosts, ensuring maximum yield and correct post-translational modifications for functional activity.
Multi-step chromatographic protocols for therapeutic-grade purity
Achieving therapeutic-grade purity is our specialty. Leveraging advanced chromatographic techniques — including Affinity, Ion Exchange, Hydrophobic Interaction, and Size Exclusion Chromatography — we develop tailored, multi-step purification protocols that deliver exceptional purity while maximizing recovery, often exceeding industry standards.
Rescuing functional protein from inclusion bodies
For challenging proteins expressed in inclusion bodies, our scientists possess deep expertise in optimizing protein refolding conditions. We employ proprietary methodologies to rescue functionally active protein from insoluble aggregates, significantly increasing product yield and viability.
Rational development for long-term stability & patient delivery
We ensure the long-term viability of your therapeutic through rational formulation development. This involves extensive excipient screening, stress testing (thermal, chemical), and buffer optimization to identify the optimal liquid or frozen dosage form. Our goal is to maximize shelf-life, maintain functional activity, and ensure patient-friendly delivery, mitigating aggregation and degradation risks for successful clinical trials.
Enhancing therapeutic performance and manufacturability
Enhance your therapeutic's performance and manufacturability. Our capabilities in site-directed mutagenesis and protein engineering are utilized to improve stability, increase activity, optimize half-life, reduce immunogenicity, or facilitate purification — giving your candidate a competitive edge.
Critical potency & activity data for regulatory submissions
We develop and implement robust, qualified biological and binding assays (ELISA, SPR, cell-based assays) to measure product activity and potency, providing the critical data necessary to demonstrate efficacy and support regulatory submissions.
Rigorous characterization at every development stage
Quality is ensured through rigorous characterization. We utilize a comprehensive suite of analytical technologies to confirm structural integrity, homogeneity, identity, and purity at every stage of development — providing the complete data trail required for regulatory confidence.
Protein assessment & feasibility
Host selection & yield maximization
Therapeutic-grade purity
Shelf-life & dosage optimization
CMC documentation & tech transfer